Everolimus Decreases [U-¹³C]glucose Utilization by Pyruvate Carboxylase in Breast Cancer Cells In Vitro and In Vivo

Researchers investigated whether the effects of a drug combination on tumor size is reflected in changes in tumor metabolism using [U-13C]glucose labeling in a triple negative breast cancer xenograft model.